{
    "ticker": "INDV",
    "name": "Indivior PLC",
    "description": "Indivior PLC is a global pharmaceutical company focused on the treatment of addiction and other mental health conditions. Founded in 2014 as a spin-off from Reckitt Benckiser, Indivior is headquartered in Richmond, Virginia, USA. The company is best known for its leading medication, Suboxone, which helps individuals struggling with opioid dependence. Indivior is dedicated to improving treatment outcomes for patients, and its portfolio includes innovative therapies designed to address the needs of those with substance use disorders. The company invests heavily in research and development to bring new solutions to market, aiming to advance the science of addiction treatment and enhance patient care. With a strong commitment to public health, Indivior collaborates with healthcare professionals, advocacy groups, and governmental bodies to raise awareness about addiction and improve access to effective treatments. Indivior's mission is to transform lives by providing access to the best possible treatment for addiction, fostering recovery, and supporting various initiatives that promote mental health.",
    "industry": [
        "Pharmaceuticals",
        "Healthcare"
    ],
    "headquarters": "Richmond, Virginia, USA",
    "founded": "2014",
    "website": "https://www.indivior.com",
    "ceo": "Mark Crossley",
    "social_media": {
        "twitter": "https://twitter.com/Indivior",
        "linkedin": "https://www.linkedin.com/company/indivior/"
    },
    "investor_relations": "https://www.indivior.com/investors/",
    "key_executives": [
        {
            "name": "Mark Crossley",
            "position": "CEO"
        },
        {
            "name": "Hugh McTavish",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Addiction Treatments",
            "products": [
                "Suboxone",
                "Bunavail",
                "Zubsolv"
            ]
        }
    ],
    "seo": {
        "meta_title": "Indivior PLC | Leading Provider of Addiction Treatments",
        "meta_description": "Explore Indivior PLC, dedicated to transforming the treatment of addiction and improving patient outcomes. Learn about our innovative therapies and commitment to public health.",
        "keywords": [
            "Indivior",
            "Addiction Treatment",
            "Suboxone",
            "Mental Health",
            "Pharmaceuticals"
        ]
    },
    "faq": [
        {
            "question": "What does Indivior specialize in?",
            "answer": "Indivior specializes in the treatment of addiction and mental health conditions, primarily through innovative medications."
        },
        {
            "question": "Who is the CEO of Indivior?",
            "answer": "Mark Crossley is the CEO of Indivior PLC."
        },
        {
            "question": "Where is Indivior headquartered?",
            "answer": "Indivior is headquartered in Richmond, Virginia, USA."
        },
        {
            "question": "What are Indivior's main products?",
            "answer": "Indivior's main products include Suboxone, Bunavail, and Zubsolv."
        },
        {
            "question": "When was Indivior founded?",
            "answer": "Indivior was founded in 2014."
        }
    ],
    "competitors": [
        "NDAQ",
        "APHA",
        "PRTA"
    ],
    "related_stocks": [
        "PFE",
        "JNJ",
        "ABBV",
        "MRK"
    ]
}